Last Updated

18 Jan 2019

Open consultation on WHO prioritization framework for the R&D of malaria health products

Cover page of Analysis of research and development priorities for malaria – working paper

WHO is undertaking a consultative process to solicit inputs into a prioritization framework for the research and development (R&D) of malaria health products. A draft report “Analysis of Malaria R&D Priorities identifies five key challenges that represent threats or barriers to achieving the WHO Global Technical Strategy for Malaria 2016–2030 goals. This early copy of the report is being shared at a time when WHO is exploring how best to guide and support the development of priority solutions to meet public health needs.

WHO welcomes feedback on this draft report until 28 February 2019, including the correction of errors or omissions, updates to product development pipelines, and perspectives on the approach to prioritization.

The report and prioritization framework were developed by the MESA Alliance (MESA), the WHO Global Observatory on health R&D and the WHO Global Malaria Programme (WHO GMP).

For more information on the background of the analysis of Malaria R&D Priorities, please see announcement on WHO Global Observatory on Health R&D: https://www.who.int/research-observatory/analyses/malaria/en/index1.html.

For direct access to review the working paper, please visit and download the document from here: https://www.who.int/research-observatory/analyses/malaria_rd_priorities_working_paper.pdf?ua=1.

Comments should be sent to RDmalaria@who.int  by 28 February 2019.